GPCR Target: MOR GTPcS assays were conducted at Multispan Inc. (Hayward, CA) in membranes obtained from stably transfected CHO cell expressing the MOR receptor (CHO-K1 Multispan Inc., C1350-1a) using SPA beads (Perkin Elmer, RPNQ0001).

Authors: Beth Youngblood, Kevin Li, Donald R. Gehlert, Julio C. Medina and Neil Schwartz

Company: Epiodyne Inc., San Francisco, California and R2M Pharma Inc., South San Francisco, California

Journal: Journal of Pharmacology and Experimental Therapeutics August 2021, 378 (2) 133-145